The New York Times: Trump Promises Lower Drug Prices, but Drops Populist Solutions

Mark Merritt said the real problem was the high prices set by drugmakers. “Getting rid of rebates and other price concessions would leave patients and payers, including Medicaid and Medicare, at the mercy of drug manufacturers’ pricing strategies,” Mr. Merritt said.